Robert Eugene Kristal - 07 Jun 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Chief Financial Officer
Signature
/s/ Robert Kristal
Issuer symbol
BRTX
Transactions as of
07 Jun 2022
Net transactions value
+$912
Form type
4
Filing time
07 Jun 2022, 12:22:14 UTC
Previous filing
11 Apr 2022
Next filing
15 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Purchase $912 +200 +2.6% $4.56 7,800 07 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Stock Option 10,490 07 Jun 2022 Common Stock 10,490 $13.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.